Methyl 3-bromo-5-fluoro-4-nitrobenzoate, 95.0%, 10g

(2E)-3-(2-hydroxyphenyl)acrylic acid, 98.0%, 5g

5-Fluoro-6-methoxy-2,3-dihydro-1H-inden-1-amine, 98%, 250mg

4-Fluoroisobenzofuran-1(3H)-one, 95.0%, 1g

2-(2-Fluorophenyl)ethylamine>98.0%(GC)(T)25g

Powder flasks, 500 ml, 1 Piece

(E)-N'-(3,5-Dibromo-2-hydroxybenzylidene)nicotinohydrazide, 97%, 5g

(E)-ETHYL 3-(2-FLUORO-5-NITROPHENYL)ACRYLATE, 95.0%, 100mg

5-Methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-amine, 100mg

Fmoc-R-3-amino-4-(3-trifluoromethylphenyl)-butyric acid, 97%, 250mg

2-(1-Piperazinylcarbonyl)-1,4-benzodioxane Hydrochloride>98.0%(HPLC)5g

(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one (Ibrutinib Impurity), 97%, 50mg

4-Ethoxy-2-fluorobenzoyl chloride, 5g